Table 6.

Overview of the patients’ functional recovery (post-test) in both domains, lesion volume, and percentage of damaged tissue in particular white matter tracts.

Pat. (base)	Outcome after 7-week therapy phase		Lesion volume to specific white matter tracts
	Motor recovery	Language recovery	CST	SLF	AF
1 (M+/L+)	Non-responder WMFT (o), DGI (o)	Non-responder AAT (o), LEMO−	–	5,115	1,196
2 (M−/L+)	Strong responder WMFT+, DGI+	Non-responder AAT (o), LEMO (o)	1,057	1,916	736
3 (M+/L−)	Partial responder WMFT+, DGI (o)	Strong responder AAT+, LEMO+	568	7,188	3,944
4 (M−/L−)	Non-responder WMFT (o), DGI (o)	Non-responder AAT (o), LEMO (o)	1,643	16,462	7,458

+, Significant improvement; (o), no change; −, significant deterioration. Non-responder, patient showed no positive response to motor or language therapy; partial responder, partial positive response, i.e., significant improvement in one of the applied tests; strong responder, strong positive response, i.e., significant improvement in both applied tests; –, no lesion measured; CST, corticospinal tract; SLF, superior longitudinal fasciculus; AF, arcuate fasciculus.

Lesion volume was calculated within the FLAIR data (voxels).